Welcome to Nanovi

 

Nanovi is developing products based on advanced biomaterials for use in the treatment of cancer.

Nanovi’s first product (BioXmark) is an injectable liquid tissue marker to improve precision in radiation treatment of patients with cancer.

BioXmark has the potential to increase radiotherapy standards with minimal changes in current routines and equipment. It will be available for commercial use in Europe in 2015 with clinical data to document its benefit.